tiprankstipranks
Advertisement
Advertisement

PSTV Stock Latest News

Plus Therapeutics enters pact with Ephemeral for AI execution platform
The FlyPlus Therapeutics enters pact with Ephemeral for AI execution platform
3d ago
PSTV
Plus Therapeutics Stockholders Back Directors and Incentive Plan
PremiumCompany Announcements
Plus Therapeutics Stockholders Back Directors and Incentive Plan
7d ago
8K
PSTV
Plus Therapeutics reports Q1 EPS ($1.05), consensus (87c)
PremiumThe Fly
Plus Therapeutics reports Q1 EPS ($1.05), consensus (87c)
7d ago
PSTV
Plus Therapeutics Regains Nasdaq Listing Compliance After Reverse Split
PremiumCompany Announcements
Plus Therapeutics Regains Nasdaq Listing Compliance After Reverse Split
1M ago
8K
PSTV
Plus Therapeutics regains compliance with Nasdaq minimum bid price requirement
PremiumThe Fly
Plus Therapeutics regains compliance with Nasdaq minimum bid price requirement
1M ago
PSTV
PSTV Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsPSTV Upcoming Earnings Report: What to Expect?
1M ago
PSTV
Plus Therapeutics Appoints New Chief Development Officer
Premium
Company Announcements
Plus Therapeutics Appoints New Chief Development Officer
1M ago
8K
PSTV
Plus Therapeutics appoints Eric Daniels as chief development officer
Premium
The Fly
Plus Therapeutics appoints Eric Daniels as chief development officer
1M ago
PSTV
Plus Therapeutics Gains FDA Orphan Status for REYOBIQ
PremiumCompany Announcements
Plus Therapeutics Gains FDA Orphan Status for REYOBIQ
1M ago
8K
PSTV
Plus Therapeutics granted Orphan Drug Designation for Reyobiq
PremiumThe Fly
Plus Therapeutics granted Orphan Drug Designation for Reyobiq
1M ago
PSTV
Plus Therapeutics price target lowered to $12 from $37.50 at Maxim
PremiumThe Fly
Plus Therapeutics price target lowered to $12 from $37.50 at Maxim
1M ago
PSTV
Plus CNSide Cerebrospinal Fluid Tumor Cell Enumeration test gets AMA PLA code
PremiumThe Fly
Plus CNSide Cerebrospinal Fluid Tumor Cell Enumeration test gets AMA PLA code
2M ago
PSTV
Plus Therapeutics’ treatment of malignant glioma granted FDA orphan designation
PremiumThe FlyPlus Therapeutics’ treatment of malignant glioma granted FDA orphan designation
2M ago
PSTV
Plus Therapeutics Enacts Reverse Stock Split to Maintain Listing
Premium
Company Announcements
Plus Therapeutics Enacts Reverse Stock Split to Maintain Listing
2M ago
8K
PSTV
Plus Therapeutics Inc (USA) trading halted, news pending
Premium
The Fly
Plus Therapeutics Inc (USA) trading halted, news pending
2M ago
PSTV
Plus Therapeutics downgraded to Hold from Buy at D. Boral Capital
PremiumThe Fly
Plus Therapeutics downgraded to Hold from Buy at D. Boral Capital
2M ago
PSTV
Plus Therapeutics announces 1-for-25 reverse stock split
PremiumThe Fly
Plus Therapeutics announces 1-for-25 reverse stock split
2M ago
PSTV
Plus Therapeutics Adds Industry Veteran Ronald Andrews to Board
PremiumCompany Announcements
Plus Therapeutics Adds Industry Veteran Ronald Andrews to Board
2M ago
8K
PSTV
Plus Therapeutics’ CNSide assay may reduce healthcare costs
PremiumThe Fly
Plus Therapeutics’ CNSide assay may reduce healthcare costs
2M ago
PSTV
Plus Therapeutics: Advancing Reyobiq Pipeline and CNSide Commercialization Underpinned by Strong Cash Runway to 2027
PremiumRatingsPlus Therapeutics: Advancing Reyobiq Pipeline and CNSide Commercialization Underpinned by Strong Cash Runway to 2027
2M ago
PSTV
Plus Therapeutics Sets 2026 Virtual Annual Stockholder Meeting
Premium
Company Announcements
Plus Therapeutics Sets 2026 Virtual Annual Stockholder Meeting
2M ago
8K
PSTV
Plus Therapeutics reports Q4 EPS (29c), consensus (4c)
Premium
The Fly
Plus Therapeutics reports Q4 EPS (29c), consensus (4c)
2M ago
PSTV

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >